MedTrace Logo

The Effectiveness of a Mindfulness Based Program on Short- Form Video Addiction in Adolescents

NCT07374666 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2026-01-30

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness of a mindfulness-based program in reducing short form video addiction among adolescents. The study is designed as a randomized controlled trial with a pre-test, post-test, and follow-up design, including an intervention group and a control group.

Research Hypothesis:

Adolescents who participate in the Mindfulness-Based Program will have significantly lower short video addiction scores compared to those in the control group.

Conditions

Interventions

BEHAVIORAL

Mindfulness Based Program

The program will last for 8 weeks, with one session held each week. Each session will focus on specific themes such as mindfulness, acceptance, and compassion. The sessions include explanations of these concepts as well as practical exercises like breath awareness and body scan. At the end of each week, participants will be assigned homework to help reinforce their practice. Session Outline: Session 1: Introduction and Mindfulness Session 2: Sensations Session 3: The Wandering Mind Session 4: Challenges in Daily Life Session 5: Reactions Session 6: Compassion Session 7: Acceptance Session 8: Sustainability and Maintaining Practice

Sponsors & Collaborators

  • Istanbul University - Cerrahpasa

    lead OTHER

Principal Investigators

  • Ozge Sukut, PhD · Istanbul University - Cerrahpasa

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-01
Primary Completion
2026-03-31
Completion
2026-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07374666 on ClinicalTrials.gov